Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma.

JSON

Lauss M, Donia M, Harbst K, Andersen R, Mitra S, Rosengren F, Salim M, Vallon-Christersson J, Törngren T, Kvist A, Ringnér M, Svane IM, Jönsson G

Nat Commun 11 (1) 1714 [2020-04-01; online 2020-04-01]

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

PubMed 32238805

DOI 10.1038/s41467-020-15531-2

Crossref 10.1038/s41467-020-15531-2

pmc: PMC7113240
pii: 10.1038/s41467-020-15531-2